Jeff Yass’s LeMaitre Vascular LMAT Stock Holding History

Jeff Yass’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,100	Closed	-$271K	–	13056
2025 Q3	$271K	Buy	+3,100	New	+$277K	﹤0.01%	10342
2024 Q2	–	Sell	-7,800	Closed	-$518K	–	12726
2024 Q1	$518K	Buy	+7,800	New	+$481K	﹤0.01%	8421
2023 Q4	–	Sell	-4,000	Closed	-$218K	–	12885
2023 Q3	$218K	Buy	+4,000	New	+$237K	﹤0.01%	10045
2021 Q3	–	Sell	-4,500	Closed	-$275K	–	13205
2021 Q2	$275K	Sell	4,500 -1,600	-26%	-$85K	﹤0.01%	10967
2021 Q1	$298K	Buy	+6,100	New	+$286K	﹤0.01%	10612
2020 Q4	–	Sell	-7,300	Closed	-$237K	–	11426
2020 Q3	$237K	Buy	+7,300	New	+$219K	﹤0.01%	9174
2020 Q1	–	Sell	-7,900	Closed	-$284K	–	10603
2019 Q4	$284K	Buy	+7,900	New	+$273K	﹤0.01%	8134
2019 Q1	–	Sell	-9,700	Closed	-$229K	–	9409
2018 Q4	$229K	Sell	9,700 -2,600	-21%	-$71K	﹤0.01%	7494
2018 Q3	$477K	Buy	+12,300	New	+$443K	﹤0.01%	6622

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Jeff Yass's LMAT Position: Q2 2026 in Review

Jeff Yass sold out of LeMaitre Vascular (LMAT) in Q2 2026, closing a stake of 9,694 shares — an estimated $1.06M sold.

Jeff Yass first reported a position in LMAT in Q4 2016 and held it in 15 quarters. The position peaked at $2.17M in Q2 2025. 325 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

Jeff Yass reported no remaining LeMaitre Vascular position as of Q2 2026 after selling out during the quarter.
Jeff Yass sold 9,694 LeMaitre Vascular shares in Q2 2026, an estimated $1.06M.
Jeff Yass first reported a position in LeMaitre Vascular in Q4 2016 and held it in 15 quarters.
Jeff Yass's LeMaitre Vascular position peaked at $2.17M in Q2 2025.
325 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.